Here's how NATURE.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

NATURE . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Nature.com Make Money
  6. How Much Does Nature.com Make
  7. Keywords
  8. Topics
  9. Questions
  10. Schema
  11. External Links
  12. Analytics And Tracking
  13. Libraries
  14. Hosting Providers
  15. CDN Services

We are analyzing https://www.nature.com/articles/s41401-021-00835-w.

Title:
Therapeutic potential of colchicine in cardiovascular medicine: a pharmacological review | Acta Pharmacologica Sinica
Description:
Colchicine is an ancient herbal drug derived from Colchicum autumnale. It was first used to treat familial Mediterranean fever and gout. Based on its unique efficacy as an anti-inflammatory agent, colchicine has been used in the therapy of cardiovascular diseases including coronary artery disease, atherosclerosis, recurrent pericarditis, vascular restenosis, heart failure, and myocardial infarction. More recently, colchicine has also shown therapeutic efficacy in alleviating cardiovascular complications of COVID-19. COLCOT and LoDoCo2 are two milestone clinical trials that confirm the curative effect of long-term administration of colchicine in reducing the incidence of cardiovascular events in patients with coronary artery disease. There is growing interest in studying the anti-inflammatory mechanisms of colchicine. The anti-inflammatory action of colchicine is mediated mainly through inhibiting the assembly of microtubules. At the cellular level, colchicine inhibits the following: (1) endothelial cell dysfunction and inflammation; (2) smooth muscle cell proliferation and migration; (3) macrophage chemotaxis, migration, and adhesion; (4) platelet activation. At the molecular level, colchicine reduces proinflammatory cytokine release and inhibits NF-κB signaling and NLRP3 inflammasome activation. In this review, we summarize the current clinical trials with proven curative effect of colchicine in treating cardiovascular diseases. We also systematically discuss the mechanisms of colchicine action in cardiovascular therapeutics. Altogether, colchicine, a bioactive constituent from an ancient medicinal herb, exerts unique anti-inflammatory effects and prominent cardiovascular actions, and will charter a new page in cardiovascular medicine.
Website Age:
30 years and 10 months (reg. 1994-08-11).

Matching Content Categories {📚}

  • Education
  • Health & Fitness
  • Science

Content Management System {📝}

What CMS is nature.com built with?

Custom-built

No common CMS systems were detected on Nature.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of nature.com audience?

🌆 Monumental Traffic: 20M - 50M visitors per month


Based on our best estimate, this website will receive around 41,360,422 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Nature.com Make Money? {💸}


Display Ads {🎯}


The website utilizes display ads within its content to generate revenue. Check the next section for further revenue estimates.

Ads are managed by yourbow.com. Particular relationships are as follows:

Direct Advertisers (10)
google.com, pmc.com, doceree.com, yourbow.com, audienciad.com, onlinemediasolutions.com, advibe.media, aps.amazon.com, getmediamx.com, onomagic.com

Reseller Advertisers (38)
conversantmedia.com, rubiconproject.com, pubmatic.com, appnexus.com, openx.com, smartadserver.com, lijit.com, sharethrough.com, video.unrulymedia.com, google.com, yahoo.com, triplelift.com, onetag.com, sonobi.com, contextweb.com, 33across.com, indexexchange.com, media.net, themediagrid.com, adform.com, richaudience.com, sovrn.com, improvedigital.com, freewheel.tv, smaato.com, yieldmo.com, amxrtb.com, adyoulike.com, adpone.com, criteo.com, smilewanted.com, 152media.info, e-planning.net, smartyads.com, loopme.com, opera.com, mediafuse.com, betweendigital.com

How Much Does Nature.com Make? {💰}


Display Ads {🎯}

$521,200 per month
Our calculations suggest that Nature.com earns between $347,470 and $955,541 monthly online from display advertisements.

Keywords {🔍}

pubmed, article, google, scholar, cas, colchicine, central, coronary, disease, atherosclerosis, cardiovascular, activation, patients, inflammation, med, nature, heart, cell, biol, httpsdoiorg, httpsdoiorgs, clin, acute, human, effect, pharmacol, circulation, cells, diseases, antiinflammatory, res, therapeutic, artery, restenosis, inflammasome, vasc, cardiol, atherosclerotic, therapy, endothelial, smooth, platelet, effects, thromb, trial, content, pericarditis, muscle, research, treatment,

Topics {✒️}

nature portfolio permissions reprints privacy policy jama netw open advertising nature suo-wen xu reducing tuba/alpha-tubulin acetylation social media research teams project open biochem innovative research team alleviating cardiovascular complications oxidized low-density lipoprotein author information authors oxidised low-density lipoproteins colchicine toxicity—clinical features crystal-induced neutrophil activation microtubule-mediated nf-kappab activation microtubule-driven spatial arrangement inhibits nf-κb signaling acute myocardial infarction tnf-alpha signaling pathway author correspondence glycoprotein vi stimulation chengxue helena qin cardiovascular complications modulating srf-myocd activation nf-kappab nuclear translocation translational research signal transduction pathway bare-metal stent restenosis microtubule-disassembling drug coronary artery disease nf-kappab signaling pathway early leukocyte development hefei municipal development research permissions anti-inflammatory mechanisms anti-inflammatory agent myocardial infarction personal data access colchicine-pci randomized trial long-term colchicine treatment anti-inflammatory treatment treating cardiovascular diseases coron artery dis nidorf sm

Questions {❓}

  • Increased asymmetric dimethylarginine levels in young men with familial Mediterranean fever (FMF): is it early evidence of interaction between inflammation and endothelial dysfunction in FMF?
  • Is P-glycoprotein (ABCB1) a phase 0 or a phase 3 colchicine transporter depending on colchicine exposure conditions?
  • Mean platelet volume and beta-thromboglobulin levels in familial Mediterranean fever: effect of colchicine use?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Therapeutic potential of colchicine in cardiovascular medicine: a pharmacological review
         description:Colchicine is an ancient herbal drug derived from Colchicum autumnale. It was first used to treat familial Mediterranean fever and gout. Based on its unique efficacy as an anti-inflammatory agent, colchicine has been used in the therapy of cardiovascular diseases including coronary artery disease, atherosclerosis, recurrent pericarditis, vascular restenosis, heart failure, and myocardial infarction. More recently, colchicine has also shown therapeutic efficacy in alleviating cardiovascular complications of COVID-19. COLCOT and LoDoCo2 are two milestone clinical trials that confirm the curative effect of long-term administration of colchicine in reducing the incidence of cardiovascular events in patients with coronary artery disease. There is growing interest in studying the anti-inflammatory mechanisms of colchicine. The anti-inflammatory action of colchicine is mediated mainly through inhibiting the assembly of microtubules. At the cellular level, colchicine inhibits the following: (1) endothelial cell dysfunction and inflammation; (2) smooth muscle cell proliferation and migration; (3) macrophage chemotaxis, migration, and adhesion; (4) platelet activation. At the molecular level, colchicine reduces proinflammatory cytokine release and inhibits NF-κB signaling and NLRP3 inflammasome activation. In this review, we summarize the current clinical trials with proven curative effect of colchicine in treating cardiovascular diseases. We also systematically discuss the mechanisms of colchicine action in cardiovascular therapeutics. Altogether, colchicine, a bioactive constituent from an ancient medicinal herb, exerts unique anti-inflammatory effects and prominent cardiovascular actions, and will charter a new page in cardiovascular medicine.
         datePublished:2022-01-19T00:00:00Z
         dateModified:2022-01-19T00:00:00Z
         pageStart:2173
         pageEnd:2190
         sameAs:https://doi.org/10.1038/s41401-021-00835-w
         keywords:
            colchicine
            anti-inflammatory drug
            cardiovascular diseases
            coronary artery disease
            atherosclerosis
            recurrent pericarditis
            restenosis
            heart failure
            myocardial infarction
            cardiovascular complications of COVID-19
            microtubules
            NF-κB
            NLRP3 inflammasome
            Biomedicine
            general
            Pharmacology/Toxicology
            Medical Microbiology
            Immunology
            Internal Medicine
            Vaccine
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41401-021-00835-w/MediaObjects/41401_2021_835_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41401-021-00835-w/MediaObjects/41401_2021_835_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41401-021-00835-w/MediaObjects/41401_2021_835_Fig3_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41401-021-00835-w/MediaObjects/41401_2021_835_Fig4_HTML.png
         isPartOf:
            name:Acta Pharmacologica Sinica
            issn:
               1745-7254
               1671-4083
            volumeNumber:43
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer Nature Singapore
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Fan-shun Zhang
               affiliation:
                     name:University of Science and Technology of China
                     address:
                        name:Institute of Endocrine and Metabolic Diseases, The First Affiliated Hospital of USTC, Division of Life Science and Medicine, University of Science and Technology of China, Hefei, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Qing-ze He
               affiliation:
                     name:University of Science and Technology of China
                     address:
                        name:Institute of Endocrine and Metabolic Diseases, The First Affiliated Hospital of USTC, Division of Life Science and Medicine, University of Science and Technology of China, Hefei, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Chengxue Helena Qin
               affiliation:
                     name:Monash University (Parkville Campus)
                     address:
                        name:Faculty of Pharmacy and Pharmaceutical Sciences, Monash Institute of Pharmaceutical Sciences, Monash University (Parkville Campus), Parkville, Australia
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Peter J. Little
               affiliation:
                     name:University of the Sunshine Coast
                     address:
                        name:Sunshine Coast Health Institute, University of the Sunshine Coast, Birtinya, Australia
                        type:PostalAddress
                     type:Organization
                     name:The University of Queensland
                     address:
                        name:School of Pharmacy, The University of Queensland, Woolloongabba, Australia
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jian-ping Weng
               affiliation:
                     name:University of Science and Technology of China
                     address:
                        name:Institute of Endocrine and Metabolic Diseases, The First Affiliated Hospital of USTC, Division of Life Science and Medicine, University of Science and Technology of China, Hefei, China
                        type:PostalAddress
                     type:Organization
                     name:University of Science & Technology of China
                     address:
                        name:Biomedical Sciences and Health Laboratory of Anhui Province, University of Science & Technology of China, Hefei, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Suo-wen Xu
               url:http://orcid.org/0000-0002-5488-5217
               affiliation:
                     name:University of Science and Technology of China
                     address:
                        name:Institute of Endocrine and Metabolic Diseases, The First Affiliated Hospital of USTC, Division of Life Science and Medicine, University of Science and Technology of China, Hefei, China
                        type:PostalAddress
                     type:Organization
                     name:University of Science & Technology of China
                     address:
                        name:Biomedical Sciences and Health Laboratory of Anhui Province, University of Science & Technology of China, Hefei, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Therapeutic potential of colchicine in cardiovascular medicine: a pharmacological review
      description:Colchicine is an ancient herbal drug derived from Colchicum autumnale. It was first used to treat familial Mediterranean fever and gout. Based on its unique efficacy as an anti-inflammatory agent, colchicine has been used in the therapy of cardiovascular diseases including coronary artery disease, atherosclerosis, recurrent pericarditis, vascular restenosis, heart failure, and myocardial infarction. More recently, colchicine has also shown therapeutic efficacy in alleviating cardiovascular complications of COVID-19. COLCOT and LoDoCo2 are two milestone clinical trials that confirm the curative effect of long-term administration of colchicine in reducing the incidence of cardiovascular events in patients with coronary artery disease. There is growing interest in studying the anti-inflammatory mechanisms of colchicine. The anti-inflammatory action of colchicine is mediated mainly through inhibiting the assembly of microtubules. At the cellular level, colchicine inhibits the following: (1) endothelial cell dysfunction and inflammation; (2) smooth muscle cell proliferation and migration; (3) macrophage chemotaxis, migration, and adhesion; (4) platelet activation. At the molecular level, colchicine reduces proinflammatory cytokine release and inhibits NF-κB signaling and NLRP3 inflammasome activation. In this review, we summarize the current clinical trials with proven curative effect of colchicine in treating cardiovascular diseases. We also systematically discuss the mechanisms of colchicine action in cardiovascular therapeutics. Altogether, colchicine, a bioactive constituent from an ancient medicinal herb, exerts unique anti-inflammatory effects and prominent cardiovascular actions, and will charter a new page in cardiovascular medicine.
      datePublished:2022-01-19T00:00:00Z
      dateModified:2022-01-19T00:00:00Z
      pageStart:2173
      pageEnd:2190
      sameAs:https://doi.org/10.1038/s41401-021-00835-w
      keywords:
         colchicine
         anti-inflammatory drug
         cardiovascular diseases
         coronary artery disease
         atherosclerosis
         recurrent pericarditis
         restenosis
         heart failure
         myocardial infarction
         cardiovascular complications of COVID-19
         microtubules
         NF-κB
         NLRP3 inflammasome
         Biomedicine
         general
         Pharmacology/Toxicology
         Medical Microbiology
         Immunology
         Internal Medicine
         Vaccine
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41401-021-00835-w/MediaObjects/41401_2021_835_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41401-021-00835-w/MediaObjects/41401_2021_835_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41401-021-00835-w/MediaObjects/41401_2021_835_Fig3_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41401-021-00835-w/MediaObjects/41401_2021_835_Fig4_HTML.png
      isPartOf:
         name:Acta Pharmacologica Sinica
         issn:
            1745-7254
            1671-4083
         volumeNumber:43
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer Nature Singapore
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Fan-shun Zhang
            affiliation:
                  name:University of Science and Technology of China
                  address:
                     name:Institute of Endocrine and Metabolic Diseases, The First Affiliated Hospital of USTC, Division of Life Science and Medicine, University of Science and Technology of China, Hefei, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Qing-ze He
            affiliation:
                  name:University of Science and Technology of China
                  address:
                     name:Institute of Endocrine and Metabolic Diseases, The First Affiliated Hospital of USTC, Division of Life Science and Medicine, University of Science and Technology of China, Hefei, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Chengxue Helena Qin
            affiliation:
                  name:Monash University (Parkville Campus)
                  address:
                     name:Faculty of Pharmacy and Pharmaceutical Sciences, Monash Institute of Pharmaceutical Sciences, Monash University (Parkville Campus), Parkville, Australia
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Peter J. Little
            affiliation:
                  name:University of the Sunshine Coast
                  address:
                     name:Sunshine Coast Health Institute, University of the Sunshine Coast, Birtinya, Australia
                     type:PostalAddress
                  type:Organization
                  name:The University of Queensland
                  address:
                     name:School of Pharmacy, The University of Queensland, Woolloongabba, Australia
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jian-ping Weng
            affiliation:
                  name:University of Science and Technology of China
                  address:
                     name:Institute of Endocrine and Metabolic Diseases, The First Affiliated Hospital of USTC, Division of Life Science and Medicine, University of Science and Technology of China, Hefei, China
                     type:PostalAddress
                  type:Organization
                  name:University of Science & Technology of China
                  address:
                     name:Biomedical Sciences and Health Laboratory of Anhui Province, University of Science & Technology of China, Hefei, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Suo-wen Xu
            url:http://orcid.org/0000-0002-5488-5217
            affiliation:
                  name:University of Science and Technology of China
                  address:
                     name:Institute of Endocrine and Metabolic Diseases, The First Affiliated Hospital of USTC, Division of Life Science and Medicine, University of Science and Technology of China, Hefei, China
                     type:PostalAddress
                  type:Organization
                  name:University of Science & Technology of China
                  address:
                     name:Biomedical Sciences and Health Laboratory of Anhui Province, University of Science & Technology of China, Hefei, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Acta Pharmacologica Sinica
      issn:
         1745-7254
         1671-4083
      volumeNumber:43
Organization:
      name:Springer Nature Singapore
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:University of Science and Technology of China
      address:
         name:Institute of Endocrine and Metabolic Diseases, The First Affiliated Hospital of USTC, Division of Life Science and Medicine, University of Science and Technology of China, Hefei, China
         type:PostalAddress
      name:University of Science and Technology of China
      address:
         name:Institute of Endocrine and Metabolic Diseases, The First Affiliated Hospital of USTC, Division of Life Science and Medicine, University of Science and Technology of China, Hefei, China
         type:PostalAddress
      name:Monash University (Parkville Campus)
      address:
         name:Faculty of Pharmacy and Pharmaceutical Sciences, Monash Institute of Pharmaceutical Sciences, Monash University (Parkville Campus), Parkville, Australia
         type:PostalAddress
      name:University of the Sunshine Coast
      address:
         name:Sunshine Coast Health Institute, University of the Sunshine Coast, Birtinya, Australia
         type:PostalAddress
      name:The University of Queensland
      address:
         name:School of Pharmacy, The University of Queensland, Woolloongabba, Australia
         type:PostalAddress
      name:University of Science and Technology of China
      address:
         name:Institute of Endocrine and Metabolic Diseases, The First Affiliated Hospital of USTC, Division of Life Science and Medicine, University of Science and Technology of China, Hefei, China
         type:PostalAddress
      name:University of Science & Technology of China
      address:
         name:Biomedical Sciences and Health Laboratory of Anhui Province, University of Science & Technology of China, Hefei, China
         type:PostalAddress
      name:University of Science and Technology of China
      address:
         name:Institute of Endocrine and Metabolic Diseases, The First Affiliated Hospital of USTC, Division of Life Science and Medicine, University of Science and Technology of China, Hefei, China
         type:PostalAddress
      name:University of Science & Technology of China
      address:
         name:Biomedical Sciences and Health Laboratory of Anhui Province, University of Science & Technology of China, Hefei, China
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Fan-shun Zhang
      affiliation:
            name:University of Science and Technology of China
            address:
               name:Institute of Endocrine and Metabolic Diseases, The First Affiliated Hospital of USTC, Division of Life Science and Medicine, University of Science and Technology of China, Hefei, China
               type:PostalAddress
            type:Organization
      name:Qing-ze He
      affiliation:
            name:University of Science and Technology of China
            address:
               name:Institute of Endocrine and Metabolic Diseases, The First Affiliated Hospital of USTC, Division of Life Science and Medicine, University of Science and Technology of China, Hefei, China
               type:PostalAddress
            type:Organization
      name:Chengxue Helena Qin
      affiliation:
            name:Monash University (Parkville Campus)
            address:
               name:Faculty of Pharmacy and Pharmaceutical Sciences, Monash Institute of Pharmaceutical Sciences, Monash University (Parkville Campus), Parkville, Australia
               type:PostalAddress
            type:Organization
      name:Peter J. Little
      affiliation:
            name:University of the Sunshine Coast
            address:
               name:Sunshine Coast Health Institute, University of the Sunshine Coast, Birtinya, Australia
               type:PostalAddress
            type:Organization
            name:The University of Queensland
            address:
               name:School of Pharmacy, The University of Queensland, Woolloongabba, Australia
               type:PostalAddress
            type:Organization
      name:Jian-ping Weng
      affiliation:
            name:University of Science and Technology of China
            address:
               name:Institute of Endocrine and Metabolic Diseases, The First Affiliated Hospital of USTC, Division of Life Science and Medicine, University of Science and Technology of China, Hefei, China
               type:PostalAddress
            type:Organization
            name:University of Science & Technology of China
            address:
               name:Biomedical Sciences and Health Laboratory of Anhui Province, University of Science & Technology of China, Hefei, China
               type:PostalAddress
            type:Organization
      name:Suo-wen Xu
      url:http://orcid.org/0000-0002-5488-5217
      affiliation:
            name:University of Science and Technology of China
            address:
               name:Institute of Endocrine and Metabolic Diseases, The First Affiliated Hospital of USTC, Division of Life Science and Medicine, University of Science and Technology of China, Hefei, China
               type:PostalAddress
            type:Organization
            name:University of Science & Technology of China
            address:
               name:Biomedical Sciences and Health Laboratory of Anhui Province, University of Science & Technology of China, Hefei, China
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Institute of Endocrine and Metabolic Diseases, The First Affiliated Hospital of USTC, Division of Life Science and Medicine, University of Science and Technology of China, Hefei, China
      name:Institute of Endocrine and Metabolic Diseases, The First Affiliated Hospital of USTC, Division of Life Science and Medicine, University of Science and Technology of China, Hefei, China
      name:Faculty of Pharmacy and Pharmaceutical Sciences, Monash Institute of Pharmaceutical Sciences, Monash University (Parkville Campus), Parkville, Australia
      name:Sunshine Coast Health Institute, University of the Sunshine Coast, Birtinya, Australia
      name:School of Pharmacy, The University of Queensland, Woolloongabba, Australia
      name:Institute of Endocrine and Metabolic Diseases, The First Affiliated Hospital of USTC, Division of Life Science and Medicine, University of Science and Technology of China, Hefei, China
      name:Biomedical Sciences and Health Laboratory of Anhui Province, University of Science & Technology of China, Hefei, China
      name:Institute of Endocrine and Metabolic Diseases, The First Affiliated Hospital of USTC, Division of Life Science and Medicine, University of Science and Technology of China, Hefei, China
      name:Biomedical Sciences and Health Laboratory of Anhui Province, University of Science & Technology of China, Hefei, China
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(710)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Prism.js
  • Zoom.js

Emails and Hosting {✉️}

Mail Servers:

  • mxa-002c5801.gslb.pphosted.com
  • mxb-002c5801.gslb.pphosted.com

Name Servers:

  • pdns1.ultradns.net
  • pdns2.ultradns.net
  • pdns3.ultradns.org
  • pdns4.ultradns.org
  • pdns5.ultradns.info
  • pdns6.ultradns.co.uk

CDN Services {📦}

  • Crossref

6.03s.